In a regulatory filing made during market hours today, Natco Pharma announced that it has received an establishment ...

Q1FY26 revenues at ?12.7 billion, YoY growth of 142% and flat QoQ growth. This includes revenues from the acquired NRT business.

Dr Reddy's Laboratories received a Form 483 with seven observations from the USFDA for its Srikakulam-based plant in Andhra ...

Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) issued Form 483 with zero observations for its Sanand, Ahmedabad unit.

Enhance FDA compliance with our expanded training on inspection processes, common issues, and strategies for prevention. Gain insights into Form 483 and warning letter prevention, root cause ...

SMS Pharmaceuticals Share Price | USFDA has conducted the inspection from June 23-25, 2025, which concluded with zero Form 483 observation.

Granules India Ltd.'s active pharmaceutical ingredient facility in Telangana received an observation from the US Food and Drugs Administration under Form 483, according to an exchange filing. The FDA ...

On conclusion, the company received seven observations in Form-483, Natco Pharma said on Thursday. The company said it is confident of addressing the observations within the stipulated timeline.

Natco Pharma Ltd.'s pharma division in Kothur, Hyderabad, received seven observations from the US Food and Drugs Administration under Form 483, an exchange filing on Thursday said. Observations are ...

Glenmark said that the FDA has issued a Form 483 upon the conclusion of its inspection at the manufacturing facility. The federal agency reported five observations in its report; however, the ...

The issuance of a Form 483 can sometimes influence investor sentiment and lead to short-term fluctuations in a company's stock price.